NASDAQ: CRDL 1.51%

---

Buy Recommendation Issued On CRDL By B. Riley

NASDAQ: AARD 1.51%

---

AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit